Thanks @garthdaisy.
I think it's important to stress that this product is not a competitor to Admedus but rather a collaborator. The patent you've linked to specifically states that Cardiocel is a suitable material to use in conjunction with this scaffold, implying the recommended use of Cardiocel with the NeoChord product:
"In some embodiments , the region between the valve plane struts, that is in the coaptation zone of the leaflets can include a solid biomaterial positioned therein to increase the surface area for leaflet coaptation , which is particularly useful for patients suffering from functional mitral valve regurgitation . In some such embodiments , the use of web in valve to prevent regurgitation ultimately retrains and reshapes the valve such that the valve leaflets and annulus naturally revert to a more natural configuration to obtain proper coaptation over time . In such embodiments , the biomaterial can be a bioabsorbable material that is absorbed into the body over time . Suitable biomaterials can include , for example , bovine pericardium and CardioCel® ."
- Forums
- ASX - By Stock
- Response received from Wayne on LinkedIn
Thanks @garthdaisy. I think it's important to stress that this...
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M |
Open | High | Low | Value | Volume |
$18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60 | $17.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.05 | 554 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 17.880 |
1 | 47 | 17.870 |
1 | 619 | 17.860 |
1 | 37 | 17.650 |
2 | 700 | 17.550 |
Price($) | Vol. | No. |
---|---|---|
18.050 | 554 | 1 |
18.100 | 1000 | 1 |
18.200 | 343 | 2 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online